C4 Therapeutics (CCCC) Current Leases (2019 - 2025)
Historic Current Leases for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $6.2 million.
- C4 Therapeutics' Current Leases rose 1036.93% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 1036.93%. This contributed to the annual value of $5.8 million for FY2024, which is 1063.42% up from last year.
- Per C4 Therapeutics' latest filing, its Current Leases stood at $6.2 million for Q3 2025, which was up 1036.93% from $6.1 million recorded in Q2 2025.
- C4 Therapeutics' Current Leases' 5-year high stood at $6.2 million during Q3 2025, with a 5-year trough of $1.1 million in Q1 2021.
- In the last 5 years, C4 Therapeutics' Current Leases had a median value of $5.0 million in 2023 and averaged $4.1 million.
- As far as peak fluctuations go, C4 Therapeutics' Current Leases soared by 28887.0% in 2022, and later soared by 1036.93% in 2025.
- Quarter analysis of 5 years shows C4 Therapeutics' Current Leases stood at $1.3 million in 2021, then skyrocketed by 252.32% to $4.7 million in 2022, then rose by 11.04% to $5.2 million in 2023, then rose by 10.63% to $5.8 million in 2024, then grew by 7.66% to $6.2 million in 2025.
- Its Current Leases stands at $6.2 million for Q3 2025, versus $6.1 million for Q2 2025 and $5.9 million for Q1 2025.